Envestnet Asset Management Inc Ionis Pharmaceuticals Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 58,814 shares of IONS stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,814

Previous 77,415 24.03%

Holding current value

$2.24 Million

Previous $3.69 Million 36.13%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$40.06 - $51.86 $745,156 - $964,647	-18,601 Reduced 24.03%	58,814 $2.36 Million
Q2 2024 Aug 08, 2024	SELL	$36.45 - $47.7 $1.92 Million - $2.51 Million	-52,557 Reduced 40.44%	77,415 $3.69 Million
Q1 2024 May 13, 2024	SELL	$42.03 - $53.55 $147,609 - $188,067	-3,512 Reduced 2.63%	129,972 $5.63 Million
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $292,795 - $348,399	6,748 Added 5.32%	133,484 $6.75 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $3.49 Million - $4.27 Million	90,667 Added 251.37%	126,736 $5.75 Million
Q2 2023 Aug 04, 2023	BUY	$34.73 - $43.33 $20,143 - $25,131	580 Added 1.63%	36,069 $1.48 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $2,014 - $2,472	60 Added 0.17%	35,489 $1.27 Million
Q4 2022 Feb 07, 2023	SELL	$37.12 - $46.52 $142,355 - $178,404	-3,835 Reduced 9.77%	35,429 $1.34 Million
Q3 2022 Nov 10, 2022	SELL	$36.54 - $48.66 $40,230 - $53,574	-1,101 Reduced 2.73%	39,264 $1.74 Million
Q2 2022 Aug 03, 2022	SELL	$31.71 - $43.0 $1.6 Million - $2.17 Million	-50,506 Reduced 55.58%	40,365 $1.49 Million
Q1 2022 May 04, 2022	SELL	$29.88 - $37.04 $12,579 - $15,593	-421 Reduced 0.46%	90,871 $3.37 Million
Q4 2021 Feb 04, 2022	SELL	$25.61 - $35.1 $285,039 - $390,663	-11,130 Reduced 10.87%	91,292 $2.78 Million
Q3 2021 Oct 07, 2021	BUY	$33.54 - $40.55 $224,785 - $271,766	6,702 Added 7.0%	102,422 $3.44 Million
Q2 2021 Aug 04, 2021	BUY	$34.54 - $47.25 $462,836 - $633,150	13,400 Added 16.28%	95,720 $3.82 Million
Q1 2021 May 04, 2021	BUY	$42.51 - $63.78 $1.04 Million - $1.56 Million	24,489 Added 42.35%	82,320 $3.7 Million
Q4 2020 Feb 02, 2021	BUY	$45.3 - $60.27 $120,316 - $160,077	2,656 Added 4.81%	57,831 $3.27 Million
Q3 2020 Oct 09, 2020	BUY	$47.45 - $62.95 $61,020 - $80,953	1,286 Added 2.39%	55,175 $2.62 Million
Q2 2020 Jul 08, 2020	SELL	$46.85 - $61.05 $80,628 - $105,067	-1,721 Reduced 3.09%	53,889 $3.18 Million
Q1 2020 Apr 23, 2020	SELL	$41.6 - $63.4 $1,331 - $2,028	-32 Reduced 0.06%	55,610 $2.63 Million
Q4 2019 Feb 11, 2020	SELL	$53.85 - $65.27 $94,129 - $114,091	-1,748 Reduced 3.05%	55,642 $3.36 Million
Q3 2019 Oct 17, 2019	SELL	$59.06 - $72.15 $130,581 - $159,523	-2,211 Reduced 3.71%	57,390 $3.44 Million
Q2 2019 Aug 02, 2019	BUY	$62.09 - $86.14 $433,760 - $601,774	6,986 Added 13.28%	59,601 $3.83 Million
Q1 2019 May 10, 2019	SELL	$52.92 - $81.17 $463,155 - $710,399	-8,752 Reduced 14.26%	52,615 $4.27 Million
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $2.66 Million - $3.65 Million	61,367 New	61,367 $3.32 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $1.65 Million - $2.06 Million	-38,402 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $48,068 - $60,130	-1,186 Reduced 3.0%	38,402 $1.6 Million
Q1 2018 May 09, 2018	SELL	$44.08 - $55.05 $529,709 - $661,535	-12,017 Reduced 23.29%	39,588 $1.75 Million
Q4 2017 Feb 20, 2018	BUY	$50.3 - $64.39 $25,703 - $32,903	511 Added 1.0%	51,605 $2.6 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $254,862 - $333,234	5,594 Added 12.29%	51,094 $2.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	45,500	45,500 $2.31 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Ionis Pharmaceuticals Inc Transaction History